Life Sciences Archives - Page 13 of 32

Orbital Therapeutics Names Adam Raff, M.D., Ph.D., Senior Vice President of Clinical Development

September 4, 2025

Treeline Biosciences Launches First Clinical Trials and Expands Funding to $1.1 Billion

September 3, 2025

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Facility

September 2, 2025

THIS WEEK'S STORIES

Enveda Secures $150 Million Series D to Reach Unicorn Status, Enrolls First Patient in Lead Trial, and Welcomes Mikael Dolsten to Board

September 4, 2025

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, Massachusetts

September 2, 2025

Sunflower Therapeutics Awarded NIH SBIR Grant to Advance Automated Platform for VLP-Based Vaccine Manufacturing

September 3, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Inaugural Stephenson Global Prize Awards $1 Million to Dr. Frank McCormick for Breakthroughs in Pancreatic Cancer Research

Turn Therapeutics CEO and Superbug Survivor Launches Podcast ‘Breaking Brad’ to Spotlight Overlooked Medical Breakthroughs

India’s Hyderabad Among World’s Top Seven Life Sciences Clusters

Promega Commits to Science-Based Climate Targets to Reduce Global Emissions

Asahi Kasei to Build New Planova™ Filter Plant in Japan to Meet Soaring Biopharma Demand

Most Read

Boomerang Medical Secures $20 Million Series B to Advance Pivotal Neuromodulation Trial in Ulcerative Colitis

Enveda Secures $150 Million Series D to Reach Unicorn Status, Enrolls First Patient in Lead Trial, and Welcomes Mikael Dolsten to Board

VitalCare Family Practice Adopts Sunoh.ai to Reduce Burnout and Improve Patient Care

Ginkgo Bioworks and Apheris Launch Antibody Developability Consortium, Introduce AbDev AI Competition

EDITOR PICKS

Orbital Therapeutics Names Adam Raff, M.D., Ph.D., Senior Vice President of Clinical Development

Treeline Biosciences Launches First Clinical Trials and Expands Funding to $1.1 Billion

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Facility

THIS WEEK'S STORIES

Enveda Secures $150 Million Series D to Reach Unicorn Status, Enrolls First Patient in Lead Trial, and Welcomes Mikael Dolsten to Board

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, Massachusetts

Sunflower Therapeutics Awarded NIH SBIR Grant to Advance Automated Platform for VLP-Based Vaccine Manufacturing

POPULAR CATEGORY

ABOUT US

FOLLOW US